Navigation Links
Kentucky Pharmacists Event Urging Senate Minority Leader McConnell to Fix Flawed Medicaid Drug Reimbursement Rule
Date:12/3/2007

lower than the overall AMP formula

-- Requiring Medicaid payment be calculated using the weighted average

of the Medicaid generic drugs based on their actual utilization

-- Restoring the practice of using three available generic products

for the calculation; increases the maximum allowable reimbursement

from 250 percent of the AMP to 300 percent

-- Encouraging more inexpensive generic drug usage by requiring prior

authorization of brand name drugs.

CONTACT:

For more information contact Chip Riddleberger at 410-725-6024 or chip.riddleberger@ncpanet.org.


'/>"/>
SOURCE National Community Pharmacists Association
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Anthem Blue Cross and Blue Shield in Kentucky Announces the Availability of New Health Plans for Medicare Beneficiaries
2. Nurses From Across Nation Join Solidarity Caravan in Support of Striking Kentucky RNs
3. Anthem Blue Cross and Blue Shield in Kentucky Announces Release of State Health Index
4. Medco Unveils Three New Medicare Prescription Drug Plan Options for 2008 to Provide Seniors More Choice, Better Value and Specialist Pharmacists
5. CVS Caremark Celebrates American Pharmacists Month by Thanking Its 20,000 Pharmacists
6. Maryland Pharmacists Urge House Majority Leader Hoyer to Put Patients First
7. Lisa Camooso Miller Joins National Community Pharmacists as Vice President of Public Affairs
8. By 2012, Prescribing Pharmacists Could Influence $145 Billion in Drug Sales
9. CVS Pharmacists Serve a Vital Role in Helping Patients Manage Diabetes
10. Pharmacists Press Conference Urging Senate Majority Leader Harry Reid to Fix Flawed Medicaid Drug Reimbursement Rule
11. The American Pharmacists Association Supports Consumer Education About OTC Medications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...Research(TM), a revolutionary,biometric media res...urement,announced today the appointment of three...earch and development, business strategy and marke..., who deliver a combined 60 years of experience,...nd Vice President of,Strategy; Dr. Ravi Kothuri a...
(Date:11/21/2008)... Texas M. D. Anderson Cancer Center marked the beg...st cancer in Panama through the Partnership for Br... today at an event with Laura Bush, the First Lady...ijos, the First Lady of Panama. , Joining M. D...nt of State and Susan G. Komen for the Cure who ar...
(Date:11/21/2008)...Minnesotans who successfully,quit smoking will re...ion at,the Minnesota Wild game on November 24 at ...ants in The QuitCash Challenge, a new stop-smoking...(R) Services. , The grand prize winner will...l get $1,000 gift cards from Gander Mountain. , ...
(Date:11/21/2008)...entions in computerized brain,training may help p...d fuller,lives, said Jeff Zimman, Chairman of Pos... at the annual Technology Innovators Conference in...nal Center for Technology Innovation to,promote i... Zimman said cognitive training programs can a...
Breaking Medicine News(10 mins):Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2Health News:First Lady Laura Bush's Partnership for Breast Cancer Awareness and Research extends to Panama 2Health News:Lucky Quitters to Receive Big Money in Stop-Smoking Contest 2Health News:New Applications for Cognitive Training 2
...The Weizmann Institute of Science’s researchers ha...e apparently well preserved. The Proceedings of th...hed the reports of the scientists. The fossil DNA ...lation dynamics, evolution, diets and diseases, an...
...Professor Timothy Lohman and colleagues from Unive...porosis International// that supplementing post-me...r exercise makes their bone fit and prevents bone ...sity (BMD) which highly reduces the risk of develo...
...A vaccine called RotaTeq for rotavirus has been ap...o vomiting and diarrhea claims the lives of about ...one of the largest clinical trials in history, Mer...ccine on more than 70,000 children that showed it ...
...Breast Tumor Cells may develop due to changes in t...er pregnancy, according to a paper by McDaniel. Th...f The American Journal of Pathology. // The stage...ution dictate drastic changes in the tissues of th...
Other Medicine News:
(Date:11/20/2008)...RSIDE, Calif., Nov. 20 Milk. It do... than originally thought. After years of,research...peptides found in,cow,s milk that stimulate the b... To view the Multimedia News Release, go to:, http..., While developing new cancer therapies, th...
(Date:11/20/2008)...YORK, Nov. 20 Clinical data from a...35th Annual Veith Symposium shows DVT,treatment w... Bacchus,Vascular, Inc. (Santa Clara, CA) success...n about 20 minutes. , This technique, calle...es,blood flow more quickly and safely than curren...
(Date:11/19/2008)...SAND OAKS, Calif., Nov. 19 /PRNewswire-FirstCall/ ...keda Oncology Company, a subsidiary of,Takeda Pha...ounced that,enrollment in the Phase 3 MONET1 tria...ith paclitaxel and carboplatin for the first-line ...(NSCLC) has been temporarily suspended,following ...
(Date:11/19/2008)...RK, Del., Nov. 19 Isogen, a contra... sterile filling, today announced the first,phase...en was founded to,specifically address the proces...ated with the $2 billion highly-niched, low-volume...ing market segment. , Companies can invest ...
Breaking Medicine Technology:Photos: Peptides Discovered to Alleviate Chemotherapy Side Effects 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 2Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 3Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 4Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 5Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 6Amgen, Takeda and Millennium Provide Update on Phase 3 Trial of Motesanib in Patients With Non-Small Cell Lung Cancer 7Isogen Launches Major New Facility to Address Global Biopharma Demand 2Cardiome Reports First Quarter Results 19236 1Cardiome Reports First Quarter Results 19236 2Cardiome Reports First Quarter Results 19236 3Cardiome Reports First Quarter Results 19236 4Cardiome Reports First Quarter Results 19236 5PharmAthene Reports First Quarter 2008 Financial Results 5367 1PharmAthene Reports First Quarter 2008 Financial Results 5367 2PharmAthene Reports First Quarter 2008 Financial Results 5367 3PharmAthene Reports First Quarter 2008 Financial Results 5367 4PharmAthene Reports First Quarter 2008 Financial Results 5367 5PharmAthene Reports First Quarter 2008 Financial Results 5367 6PharmAthene Reports First Quarter 2008 Financial Results 5367 7Amicus Therapeutics Announces First Quarter 2008 Financial Results 5365 1Amicus Therapeutics Announces First Quarter 2008 Financial Results 5365 2Amicus Therapeutics Announces First Quarter 2008 Financial Results 5365 3Amicus Therapeutics Announces First Quarter 2008 Financial Results 5365 4Amicus Therapeutics Announces First Quarter 2008 Financial Results 5365 5Amicus Therapeutics Announces First Quarter 2008 Financial Results 5365 6Amicus Therapeutics Announces First Quarter 2008 Financial Results 5365 7Amicus Therapeutics Announces First Quarter 2008 Financial Results 5365 8Amicus Therapeutics Announces First Quarter 2008 Financial Results 5365 9Amicus Therapeutics Announces First Quarter 2008 Financial Results 5365 10Amicus Therapeutics Announces First Quarter 2008 Financial Results 5365 11Amicus Therapeutics Announces First Quarter 2008 Financial Results 5365 12Particle Sciences Adds Additional Clean Room Space 5363 1
...0, 2007 - People with a,class of rare genetic diso...ath can be successfully treated with drugs, says a...edicine and Lucile,Packard Children,s Hospital., T...r study that,prompt diagnosis coupled with a rapid...mproves the survival rates of people with,the cond...
...he Treatment of Ischemic,Stroke, GLASGOW, Scotland...ogical Technologies, Inc. (NTI) announced today th...clinical trials of,ancrod and updates on the clini...rinex (ancrod), for the treatment of acute,ischemi...ss in,Glasgow, Scotland in the United Kingdom. Vip...
Other Medicine Technology:Once-Fatal Metabolic Disorders Treatable, Says Stanford/Packard,Researcher 2Once-Fatal Metabolic Disorders Treatable, Says Stanford/Packard,Researcher 3Once-Fatal Metabolic Disorders Treatable, Says Stanford/Packard,Researcher 4Presentations at 2007 European Stroke Congress Highlights New,Direction for Viprinex (ancrod) 2Presentations at 2007 European Stroke Congress Highlights New,Direction for Viprinex (ancrod) 3Presentations at 2007 European Stroke Congress Highlights New,Direction for Viprinex (ancrod) 4
..., real-time thermal cycler used for identifying DN...ing much of the testing process, and making each r...fastest, easiest to use, and most flexible system ... accurate and consistent test results in as little...
...ection System is a high-throughput real-time PCR s...quences. An Automation Accessory combined with 384...lly suited to meet the high-throughput requirement...ns include gene expression quantitation and the de...
Sealing Mat for 384-well, Square Well Plates Available Sterile
Sealing Mat for 384-well PCR Plate, Natural
Medicine Products: